Technology News and Research

RSS

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.

6 Oct 2009

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases.

6 Oct 2009

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

PDS Biotechnology Corporation today announced that the company has completed GLP toxicology studies of its lead HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the evaluation of toxicity, all demonstrated a very safe profile of the drug and PDS Biotech's platform Versamune((TM)) technology.

6 Oct 2009

It is possible to communicate through power of thought alone: Study

New research from the University of Southampton has demonstrated that it is possible for communication from person to person through the power of thought alone.

6 Oct 2009

Mirth Corporation announces the launch of Mirth Meaningful Use Exchange

Mirth Corporation, the leader in commercial open source healthcare information technology, today announced the launch of Mirth Meaningful Use Exchange (Mirth MUx) as well as the first Mirth MUx implementation at Thayer County Health Services (TCHS).

6 Oct 2009

New line of waterproof headphones from H2O Audio

H2O Audio (www.h2oaudio.com), the leader in high performance sweatproof and waterproof headphones and accessories for active people everywhere, today unveiled three progressive new products.

6 Oct 2009

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL (“Biovail”), a subsidiary of Biovail Corporation.

6 Oct 2009

EDI hosts "United Nations of Providers and Payers" event to bring nation's largest dental groups together

EDI Health Group, Inc., (EHG), a provider of enhanced connectivity, streamlined technology and transaction solutions for patients, payers and providers in the dental industry, hosted its first "United Nations of Providers and Payers" on August 27, 2009.

6 Oct 2009

FDA Advisory Committee approves Peginterferon alfa-2b for treating metastatic melanoma

Enzon Pharmaceuticals, Inc. today announced that the FDA Oncologic Drug Advisory Committee voted in favor of recommending approval of PEGINTRON® as a treatment in addition to surgery in patients with metastatic melanoma.

6 Oct 2009

Promising alternative to use of live animals for drug testing

International Stem Cell Corporation, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO’s stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.

6 Oct 2009

Next generation remote monitoring platform to improve healthcare access

UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.

6 Oct 2009

Ingenuity Systems, Millennium Science announce a multi-year deal for Ingenuity Pathway Analysis with QFAB

Ingenuity Systems, the leading provider of information solutions for life science researchers, and Millennium Science, Ingenuity Systems' exclusive distributor for Australia and New Zealand, today announced a multi-year deal for Ingenuity Pathway Analysis (IPA) with the Queensland Facility for Advanced Bioinformatics (QFAB).

6 Oct 2009

Salix Pharmaceuticals granted rights to use Lupin's bioadhesive drug delivery technology

Pharma Major, Lupin Ltd today announced that it has granted Salix Pharmaceuticals, Ltd. the exclusive rights for the United States to its bioadhesive drug delivery technology for use with Rifaximin.

6 Oct 2009

Drug database provider First DataBank to join the Health 2.0 Accelerator consortium

First DataBank, a leading provider of integrated drug databases for the healthcare industry, today announced that it will join PharmaSURVEYOR and a growing list of "Health 2.0 companies" as participants in the Health 2.0 Accelerator, a consortium focused on promoting integration of technology and the consumer experience to advance consumer-centric health care.

6 Oct 2009

AAOS to participate in "Get Connected" electronic prescribing program

The American Academy of Orthopaedic Surgeons (AAOS) today announced their participation in "Get Connected," a program designed to help more of the nation's physicians and other prescribers use electronic prescribing.

6 Oct 2009

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.

6 Oct 2009

UCSF's Elizabeth Blackburn receives Nobel Prize in Medicine, lauded by Speaker Nancy Pelosi

Speaker Nancy Pelosi issued the following statement congratulating molecular biologist Elizabeth H. Blackburn of the University of California, San Francisco, who today was named to receive the 2009 Nobel Prize in Medicine. Dr. Blackburn shares the award with Carol W. Greider of Johns Hopkins University School of Medicine and Jack W. Szostak of Harvard Medical School for their discovery of an enzyme that plays a key role in normal cell function, as well as in cell aging and most cancers.

6 Oct 2009

Cardiovascular Systems to build new manufacturing facility in Texas

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed a 10-year lease agreement for a new 46,000-square-foot manufacturing facility in Pearland, Texas.

6 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that the company has entered an agreement with U.S. Department of Commerce's Commercial Service to become a Featured U.S. Exporter (FUSE) of bioterrorism monitoring equipment in France.

6 Oct 2009

Technology News and Research

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

It is possible to communicate through power of thought alone: Study

Mirth Corporation announces the launch of Mirth Meaningful Use Exchange

New line of waterproof headphones from H2O Audio

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

EDI hosts "United Nations of Providers and Payers" event to bring nation's largest dental groups together

FDA Advisory Committee approves Peginterferon alfa-2b for treating metastatic melanoma

Promising alternative to use of live animals for drug testing

Next generation remote monitoring platform to improve healthcare access

Ingenuity Systems, Millennium Science announce a multi-year deal for Ingenuity Pathway Analysis with QFAB

Salix Pharmaceuticals granted rights to use Lupin's bioadhesive drug delivery technology

Drug database provider First DataBank to join the Health 2.0 Accelerator consortium

AAOS to participate in "Get Connected" electronic prescribing program

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

UCSF's Elizabeth Blackburn receives Nobel Prize in Medicine, lauded by Speaker Nancy Pelosi

Cardiovascular Systems to build new manufacturing facility in Texas

Vivaldi receives US patent for live attenuated influenza vaccines

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News